Plant-made pharmaceuticals for exposure to chemical weapons
RJ Hamster
US Capital Global has been engaged by Canadian biotech firm developing plant-made pharmaceuticals for exposure to chemical weapons, such as sarin gas and ricin, currently working with the Departments of Defense of the U.K., Canada, and Australia.
US Capital Global Engaged by PlantForm Corporation as Strategic Advisor on $25 Million Capital Formation
US Capital Global has been engaged by Canadian biotech firm developing plant-made pharmaceuticals for exposure to chemical weapons, such as sarin gas and ricin, currently working with the Departments of Defense of the U.K., Canada, and Australia.
LATEST EVENTS
INVESTMENT OPPORTUNITIES
To learn more about how your business can secure the funding it needs,
contact Jeffrey Sweeney, Chairman and CEO, on jsweeney@uscapglobal.com +1 415 889 1010
or submit an online request for financing:
US Capital Global Partners, LLC | 1 Ferry Building, Suite 201, San Francisco, CA 94111
T +1 415 889 1010 | F +1 415 358 5665 | info@uscapglobal.com | www.uscapital.com
Securities offered through US Capital Global Securities, LLC (“USCGS”), member FINRA / SIPC. Private debt and equity investments are not suitable for all investors, are generally illiquid, offer no guarantee of returns, and subject investors to possible loss of principal. USCGS or its affiliates may provide advice to, be compensated by, or may from time to time acquire, hold debt or equity, or sell a position in the securities of, the companies noted herein. View USCGS’ Form CRS at www.uscgs.com/crs.html.
